Elizabeth Campos Pearce, MD in Falmouth, ME - Otolaryngology

Elizabeth Campos Pearce, MD is a Otolaryngology physician based in Falmouth, Maine. Elizabeth Campos Pearce is licensed to practice in Maine (license number MD20665) and her current practice location is 74 Lunt Rd Ste 206, Falmouth, Maine. She can be reached at her office (for appointments etc.) via phone at (207) 709-0939.

NPI number for Elizabeth Campos Pearce is 1720221401 and her current mailing address is 74 Lunt Rd Ste 206, Falmouth, Maine. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1720221401.

Contact Information

	Elizabeth Campos Pearce, MD
	74 Lunt Rd Ste 206, Falmouth, ME 04105-1996
	(207) 709-0939
	(207) 514-8213

Physician's Profile

Full Name	Elizabeth Campos Pearce
Gender	Female
Speciality	Otolaryngology
Location	74 Lunt Rd Ste 206, Falmouth, Maine
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1720221401
Provider Enumeration Date: 04/10/2009
Last Update Date: 08/19/2022

Medical Identifiers

Medical identifiers for Elizabeth Campos Pearce such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1720221401	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207Y00000X	Otolaryngology	MD20665 (Maine)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Elizabeth Campos Pearce is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Elizabeth Campos Pearce, MD 74 Lunt Rd Ste 206, Falmouth, ME 04105-1996 Ph: (207) 709-0939	Elizabeth Campos Pearce, MD 74 Lunt Rd Ste 206, Falmouth, ME 04105-1996 Ph: (207) 709-0939

News Archive

Inspire's denufosol tetrasodium TIGER-1 Phase 3 trial for CF published in AJRCCM

Inspire Pharmaceuticals, Inc. announced today that the results from its first Phase 3 clinical trial with denufosol tetrasodium for cystic fibrosis (CF), TIGER-1, have been published in the peer-reviewed publication, American Journal of Respiratory and Critical Care Medicine (AJRCCM). Denufosol is an investigational, inhaled, novel ion channel regulator currently in Phase 3 clinical development for the treatment of CF.

New preclinical data from Baxter's BAX 499 hemophilia study presented at ISTH

Baxter International Inc. announced today that new data from a series of studies on BAX 499, an investigational compound for potential subcutaneous hemophilia therapy, were presented this week during the 23rd annual congress of the International Society on Thrombosis and Haemostasis (ISTH) in Kyoto, Japan.

Study offers new insights into morphine-induced tolerance and increased pain sensitivity

A study published in the June issue of Anesthesiology has shown that a drug metabolite of the opioid morphine may be a key factor in the paradoxical increased sensitivity to pain caused by chronic morphine use. For the first time, this metabolite (called morphine-6 glucuronide, or M6G) was shown to act independently of the pain receptors typically targeted during morphine administration.

Oral liquid Hydroxyurea promising for long-term use in babies with sickle cell disease

Treating babies who have sickle cell disease (SCD) with oral liquid hydroxyurea appears to prevent the onset of long-term complications triggered by this disease, according to results of a preliminary study by investigators at St. Jude Children's Research Hospital.

Statins may improve conditions of people with rare lung disease

In the first study of its kind, researchers have found that cholesterol-lowering statins may improve the conditions of people with a rare lung disease called autoimmune pulmonary alveolar proteinosis. The research also suggested that two new tests could help diagnose the condition.

Elizabeth Campos Pearce, MD - Otolaryngology in Falmouth, ME